Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:38:49 2024-05-16 am EDT			5-day change	1st Jan Change
41.72 ^EUR	-0.81%		+7.58%	+9.91%

May. 16	Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	MT
May. 15	Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating	MT

Fresenius Medical Care AG & Co. KGaA Announces the Resignation of Carla Kriwet as Member of the Management Board

December 06, 2022 at 02:55 pm EST

Fresenius Medical Care Management AG announced that the Supervisory Board of Fresenius Medical Care Management AG has accepted the offer by Dr. Carla Kriwet to resign as member of the Management Board with effect as of the end of December 5, 2022 before.

Latest news about Fresenius Medical Care AG

Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	May. 16	MT
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating	May. 15	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Jefferies	May. 14	ZD
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	May. 13
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg	May. 13	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating	May. 13	ZD
FRESENIUS MEDCARE : adjusted target price at Barclays	May. 13	CF
Fresenius Medical sees up to 2% US dialysis growth by year-end	May. 11	RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup	May. 08	DJ
Home REIT cuts borrowings, Genflow shares restored	May. 08	AN
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	May. 08	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank sticks Neutral	May. 08	ZD
Fresenius becomes more optimistic thanks to subsidiary Kabi - exit from Vamed	May. 08	DP
Dpa-AFX Overview: COMPANIES from 08.05.2024 - 15:15	May. 08	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating	May. 08	ZD
European Midday Briefing : Stocks Buoyed by Some Solid Earnings	May. 08	DJ
Fresenius makes strong start to the year - forecast raised thanks to subsidiary Kabi	May. 08	DP
Fresenius Medical beats earnings expectations, keeps outlook; shares sink	May. 08	RE
German healthcare group Fresenius Q1 EBIT beats expectations	May. 08	RE
Strabag, Porr to Buy Portions of Fresenius' Vamed Group	May. 08	MT
Fresenius Hikes FY24 Outlook	May. 08	MT
EMEA Morning Briefing : Stock Futures Mixed as Earnings in Focus	May. 08	DJ
FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?	May. 07
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	May. 07	MT

Chart Fresenius Medical Care AG

Duration

Period

More charts

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-05-16 - Ex-dividend day for final dividend

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?

May 07, 2024 at 04:46 pm EDT

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.72 EUR

Average target price

39.48 EUR

Spread / Average Target

-5.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+9.91%	13.41B
HCA HEALTHCARE, INC.	+19.22%	85.64B
CVS HEALTH CORPORATION	-27.14%	70.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.05B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.23%	17.97B
FRESENIUS SE & CO. KGAA	+1.60%	17.58B
QUEST DIAGNOSTICS INCORPORATED	+3.30%	15.64B
REDE D'OR SÃO LUIZ S.A.	+7.44%	13.55B
NATERA, INC.	+73.32%	13.18B
TENET HEALTHCARE CORPORATION	+69.26%	12.99B

Other Healthcare Facilities & Services